Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 19Glioma 8Glioblastoma 8Meningioma 4Central Nervous System Neoplasms 4Spinal Cord Neoplasms 3Oligodendroglioma 3Ependymoma 3Astrocytoma 3Thyroid Neoplasms 2Sarcoma 2Radiation Injuries 2Neurofibromatoses 2Melanoma 2Medulloblastoma 2Lymphoma 2Gliosarcoma 2Fatigue 2Craniopharyngioma 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Social Adjustment 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pituitary Neoplasms 1Pinealoma 1Parasomnias 1Neurologic Manifestations 1Neurofibromatosis 1 1

Interventions

AZD 6244 11trametinib 4pirfenidone 3mirdametinib 2dabrafenib 2cabozantinib 2Imatinib Mesylate 2tipifarnib 1peginterferon alfa-2b 1nilotinib 1cediranib 1binimetinib 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Pharmacokinetics 1Methotrexate 1Liquid Biopsy 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Cryotherapy 1Control Groups 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibroma, Plexiform × Surveys and Questionnaires × CNS × Clear all
NCT03531814 2024-06-11

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

National Institutes of Health Clinical Center (CC)

Phase NA Completed
12 enrolled 18 charts
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡